Tempus AI Inc (TEM) USD0.0001 A

Sell:$40.45Buy:$40.53$0.41 (1.00%)

NASDAQ:0.13%
Market closed | Prices delayed by at least 15 minutes
Sell:$40.45
Buy:$40.53
Change:$0.41 (1.00%)
Market closed | Prices delayed by at least 15 minutes
Sell:$40.45
Buy:$40.53
Change:$0.41 (1.00%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. The Company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Its product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.

Key people

Eric P. Lefkofsky
Chief Executive Officer, Director
James Rogers
Chief Financial Officer
Ryan Fukushima
Chief Operating Officer
Erik J. Phelps
Executive Vice President, Chief Administrative and Legal Officer, Assistant Secretary
Andrew Polovin
Executive Vice President, General Counsel
Peter J. Barris
Independent Director
Eric D. Belcher
Independent Director
Jennifer A. Doudna
Independent Director
David R. Epstein
Independent Director
Wayne A.I. Frederick
Independent Director
Click to see more

Key facts

  • EPIC
    TEM
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US88023B1035
  • Market cap
    $7.07bn
  • Employees
    2,400
  • Shares in issue
    168.13m
  • Exchange
    NASDAQ
  • Index
    TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.